Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
206.27
-0.88 (-0.42%)
At close: Aug 27, 2026, 4:00 PM EDT
206.00
-0.27 (-0.13%)
After-hours: Aug 27, 2026, 4:55 PM EDT
Axsome Therapeutics Stock Forecast
Stock Price Forecast
According to 21 analysts polled by S&P Global, Axsome Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $285.42. The average 1-year stock price forecast is 38.37% higher than the current stock price, while the lowest is $246 (+19.26%) and the highest is $380 (+84.22%).
Price Target: $285.42 (+38.37%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Axsome Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 17 | 17 | 17 | 17 | 17 | 17 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 21 | 21 | 21 | 21 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $290 | Buy | Reiterates | $290 | +40.59% | Aug 24, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $258 | Buy | Reiterates | $258 | +25.08% | Aug 18, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $306 → $316 | Buy | Maintains | $306 → $316 | +53.20% | Aug 12, 2026 |
| Jefferies | Jefferies | Buy Maintains $380 | Buy | Maintains | $380 | +84.22% | Aug 11, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $310 | Buy | Maintains | $310 | +50.29% | Aug 11, 2026 |
Financial Forecast
Revenue This Year
971.05M
from 638.50M
Increased by 52.08%
Revenue Next Year
1.56B
from 971.05M
Increased by 60.87%
EPS This Year
-2.64
from -3.47
EPS Next Year
5.03
from -2.64
EPS and Forward PE are based on non-GAAP adjusted numbers.